[
    [
        {
            "time": "",
            "orginal_text": "高瓴资本三季度减仓：不确定增加成新常态，安全边际与成长性需要重新定位",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "减仓",
                    "不确定",
                    "安全边际",
                    "成长性"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "投资"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "高瓴资本三季度减仓：不确定增加成新常态，安全边际与成长性需要重新定位",
            "scores": {
                "News_content": "高瓴资本三季度减仓：不确定增加成新常态，安全边际与成长性需要重新定位",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "药明康德被传“变相降薪”，回应称还在讨论，CRO行业要“入冬”了？",
            "features": {
                "keywords": [
                    "药明康德",
                    "降薪",
                    "CRO行业",
                    "入冬"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "药明康德被传“变相降薪”，回应称还在讨论，CRO行业要“入冬”了？",
            "scores": {
                "News_content": "药明康德被传“变相降薪”，回应称还在讨论，CRO行业要“入冬”了？",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "公募基金持股市值创新高，社保显著加仓周期股（附表）",
            "features": {
                "keywords": [
                    "公募基金",
                    "持股市值",
                    "创新高",
                    "社保",
                    "加仓",
                    "周期股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "周期股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "公募基金持股市值创新高，社保显著加仓周期股（附表）",
            "scores": {
                "News_content": "公募基金持股市值创新高，社保显著加仓周期股（附表）",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "杭州泰格曹晓春成亚太商界影响力女性，身价 87 亿，去年套现 5.5 亿",
            "features": {
                "keywords": [
                    "杭州泰格",
                    "曹晓春",
                    "亚太商界",
                    "影响力",
                    "身价",
                    "套现"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "杭州泰格曹晓春成亚太商界影响力女性，身价 87 亿，去年套现 5.5 亿",
            "scores": {
                "News_content": "杭州泰格曹晓春成亚太商界影响力女性，身价 87 亿，去年套现 5.5 亿",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]